The utility token CRYO is generated by CryoGen and provides its holders with the access to the current and future services of the company. CryoGen has embodied best technologies and 12 years of experience in the cryonics market from the first cryocompany in Eurasia - KrioRus. CRYO is an Utility token. Being not a financial instrument, it gives holders the access to Cryogen services, which can be purchased in CryoStore. The project's mission is to enable people to prolong life through application of cutting-edge science of cryonics technology.
The opening of the NGO CRYOGEN with the Swiss jurisdiction.
2019
Start of the mass experiments on reversible cryopreservation of animal organs.
2020
The technology of euthanasia cryonics is worked out and applied. Start of the development of technologies for reliable and effective reversible cryopreservation of the mammal organs.
2021
The technology of reliable and effective reversible cryopreservation of most mammal organs has been obtained. Experiments begin with the organs of the dying people.
2022
Anabiosis technology developing for deep space flights.
Screenshots taken on 5 Feb 2018
Valeriya Udalova
Co-founder and CEO of the Russian company "KrioRus."
No participating data
Sergey Evfratov
Head of Kriorus perfusion lab. Biochemist, a molecular biologist.
No participating data
Yuriy Pichugin
Director of Science. PhD. International experience in cryobiology is 40 years.
No participating data
Igor Artyukhov
Co-Founder and Development Director of KrioRus.
No participating data
Ustin Kolbin
Director of Communications for Project Cryogen.
No participating data
Advisors (1)
Elena Serebryannikova
A financial adviser to the Cryogen project in Switzerland.
.png)
